Italia markets closed

Fagron NV (0HNZ.L)

LSE - LSE Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
15,04+0,18 (+1,18%)
Alla chiusura: 06:28PM BST

Fagron NV

Venecoweg 20A
Nazareth 9810
Belgium
32 8 001 28 80
https://www.fagron.com

Settore/i
Settore
Impiegati a tempo pieno3.282

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Rafael PadillaCEO & Executive Director1,12MN/D1978
Ms. Karin de JongCFO & Executive Director663,75kN/D1979
Ms. Vera BakkerChief Operating Officer7,5kN/D1972
Karen BergGlobal Investor Relations ManagerN/DN/DN/D
Mr. Johan VerlindenHead of Legal, Mergers & AcquisitionsN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, and patients worldwide. It operates in three segments: Essentials, Brands, and Compounding Services. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. Its products include DiluCap, a line of excipients to compound every capsule formulation; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; and SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort. In addition, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Governance aziendale

L'ISS Governance QualityScore di Fagron NV al 1 maggio 2024 è 4. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 6; diritti degli azionisti: 4; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.